BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26751583)

  • 1. Access to Bacteriologic-Based Diagnosis in Smear Positive Retreatment Tuberculosis Patients in Rural China: A Cross-Sectional Study in Three Geographic Varied Provinces.
    Zhou C; Jiang W; Yuan L; Lu W; He J; Zhao Q; Xu B
    PLoS One; 2016; 11(1):e0146340. PubMed ID: 26751583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia.
    Abdella K; Abdissa K; Kebede W; Abebe G
    BMC Public Health; 2015 Jul; 15():599. PubMed ID: 26135909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sputum bacterial load predicts multidrug-resistant tuberculosis in retreatment patients: a case-control study.
    Sander MS; Vuchas CY; Numfor HN; Nsimen AN; Abena JL; Noeske J; Van Deun A; Morgan KL
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):793-9. PubMed ID: 27155183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China.
    Liang L; Wu Q; Gao L; Hao Y; Liu C; Xie Y; Sun H; Yan X; Li F; Li H; Fang H; Ning N; Cui Y; Han L
    Thorax; 2012 Jul; 67(7):632-8. PubMed ID: 22403070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in drug-resistant tuberculosis after the implementation of the DOTS strategy in Shenzhen, China, 2000-2013.
    Zhu L; Yang YZ; Guan HY; Cheng SM; Jin YY; Tan WG; Wu QF; Liu XL; Zhao MG; Lu ZH; Jia ZW
    Int J Tuberc Lung Dis; 2017 Jul; 21(7):759-765. PubMed ID: 28633700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Better care provided to patients with tuberculosis at county designated TB hospitals (CTD) compared to non-CTDs in rural China.
    Yuan L; Zhang H; Zhou C; Jiang W; Zhao Q; Biao X
    BMC Infect Dis; 2017 Jan; 17(1):71. PubMed ID: 28086753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTBDRplus results correlate with treatment outcome in previously treated tuberculosis patients.
    Huang FL; Jin JL; Chen S; Zhou Z; Diao N; Huang HQ; Liu W; Wang Q; Weng XH; Chaisson RE; Zhang Y; Zhang WH
    Int J Tuberc Lung Dis; 2015 Mar; 19(3):319-25, i-ii. PubMed ID: 25686141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples.
    Meaza A; Kebede A; Yaregal Z; Dagne Z; Moga S; Yenew B; Diriba G; Molalign H; Tadesse M; Adisse D; Getahun M; Desta K
    BMC Infect Dis; 2017 Apr; 17(1):280. PubMed ID: 28415989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China.
    Lu Z; Jiang W; Zhang J; Lynn HS; Chen Y; Zhang S; Ma Z; Geng P; Guo X; Zhang H; Zhang Z
    PLoS One; 2019; 14(11):e0225361. PubMed ID: 31751390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
    Javaid A; Hasan R; Zafar A; Chaudry MA; Qayyum S; Qadeer E; Shaheen Z; Agha N; Rizvi N; Afridi MZ; Chima MK; Khan AR; Ghafoor A; Khan S; Awan SR; Akhtar S; Choudry K; Iqbal ZH; Ansarie M; Ahmad N
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):303-308. PubMed ID: 28225340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China.
    Hu Y; Mathema B; Wang W; Hoffner S; Kreiswirth B; Xu B
    Microb Drug Resist; 2008 Sep; 14(3):227-32. PubMed ID: 18707239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-sectional study of tuberculosis drug resistance among previously treated patients in a tertiary hospital in Accra, Ghana: public health implications of standardized regimens.
    Forson A; Kwara A; Kudzawu S; Omari M; Otu J; Gehre F; de Jong B; Antonio M
    BMC Infect Dis; 2018 Apr; 18(1):149. PubMed ID: 29606091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A-cohort study on the standard short-course chemotherapy program for drug resistant tuberculosis in the rural counties in Eastern China].
    Hu Y; Jiang WL; Wang WB; Xu B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):540-4. PubMed ID: 19040032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
    Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia.
    Demile B; Zenebu A; Shewaye H; Xia S; Guadie A
    BMC Infect Dis; 2018 May; 18(1):249. PubMed ID: 29855354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
    Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
    BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.